**Core Concept**
Hemophilia is a genetic disorder characterized by a deficiency in blood coagulation factors, leading to spontaneous bleeding and prolonged clotting times. The two main types of hemophilia are hemophilia A, caused by a deficiency in factor VIII, and hemophilia B, caused by a deficiency in factor IX.

**Why the Correct Answer is Right**
The correct answer is related to the coagulation cascade, specifically the intrinsic pathway. In hemophilia, the deficiency of factor VIII or IX leads to a failure of the coagulation cascade to proceed properly, resulting in prolonged clotting times. The rise in **thrombin-antithrombin complex (TAT)** is a marker of coagulation activation, which is increased in hemophilia due to the body's attempt to compensate for the deficiency.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because the rise in fibrin degradation products (FDPs) is more commonly associated with disseminated intravascular coagulation (DIC), not hemophilia.
* **Option B:** This option is incorrect because the decrease in antithrombin III is more commonly associated with liver disease or nephrotic syndrome, not hemophilia.
* **Option C:** This option is incorrect because the rise in D-dimer is more commonly associated with thrombotic disorders, not hemophilia.

**Clinical Pearl / High-Yield Fact**
In hemophilia, the clinical presentation can range from mild to severe, and the severity of the disease is directly related to the level of factor VIII or IX activity. Patients with hemophilia A have a higher risk of developing inhibitors against factor VIII, which can make treatment more challenging.

**Correct Answer:**
D. thrombin-antithrombin complex (TAT)